LPT
GILD icon

Legacy Private Trust’s Gilead Sciences GILD Stock Holding History

Legacy Private Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
2,167
+617
+40% +$81.3K 0.02% 237
2026
Q1 		$216K Buy
+1,550
New +$217K 0.01% 254
2016
Q4 		– Sell
-7,675
Closed -$607K – 243
2016
Q3 		$607K Sell
7,675
-8,081
-51% -$656K 0.08% 164
2016
Q2 		$1.31M Sell
15,756
-9,189
-37% -$815K 0.19% 115
2016
Q1 		$2.29M Buy
24,945
+215
+0.9% +$19.4K 0.35% 81
2015
Q4 		$2.5M Buy
24,730
+11,914
+93% +$1.24M 0.38% 73
2015
Q3 		$1.26M Buy
12,816
+776
+6% +$86.2K 0.2% 120
2015
Q2 		$1.41M Buy
12,040
+1,690
+16% +$185K 0.21% 118
2015
Q1 		$1.02M Hold
10,350
– – 0.15% 138
2014
Q4 		$976K Buy
10,350
+200
+2% +$20.7K 0.14% 149
2014
Q3 		$1.08M Sell
10,150
-150
-1% -$14.7K 0.17% 143
2014
Q2 		$854K Buy
+10,300
New +$802K 0.13% 149

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legacy Private Trust's GILD Position: Q2 2026 in Review

Legacy Private Trust increased its Gilead Sciences (GILD) stake by 40% in Q2 2026, buying an estimated $81.3K and bringing the position to 2,167 shares worth $274K. The position accounts for 0.02% of the portfolio, ranked #237.

Legacy Private Trust first reported a position in GILD in Q2 2014 and has held it in 12 quarters since. The position peaked at $2.5M in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Legacy Private Trust held 2,167 shares of Gilead Sciences worth $274K as of Q2 2026.
  • Legacy Private Trust bought 617 Gilead Sciences shares in Q2 2026, an estimated $81.3K.
  • Gilead Sciences made up 0.02% of Legacy Private Trust's portfolio in Q2 2026, its #237 holding.
  • Legacy Private Trust first reported a position in Gilead Sciences in Q2 2014 and has held it in 12 quarters since.
  • Legacy Private Trust's Gilead Sciences position peaked at $2.5M in Q4 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Legacy Private Trust's 13F filing for Q2 2026, filed 21 Jul 2026.